MYCARDIUM AI LIMITEDActive

Company number 14036648Private limited companyIncorporated 2022

Key figures

£1,980,403+34.8%
Net assets 2024/25
+400.2%
Average annual growth 2022/23–2024/25
0500 k1 m1.5 m2 m2022/232023/242024/25

Like most small UK companies, MYCARDIUM AI LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02 m4 m2022/232023/242024/25
Filed accounts2022/23–2024/25
2022/232023/242024/25
Cash at bank and in hand147,718885,675757,711
Total assets441,7891,952,5293,060,739
Total liabilities362,622483,6021,080,336
Net assets / total equity79,1671,468,9271,980,403
Average number of employees4140

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company

As described in the company's latest filed accounts.

Summary: MYCARDIUM AI LIMITED

Company

MYCARDIUM AI LIMITED is a private limited company registered with Companies House under company number 14036648. It was incorporated on 8 Apr 2022. Its status is active. The registered office is in Liverpool (L7). Its nature of business (SIC 2007) is other business support service activities n.e.c. (82990).

Accounts

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files small company accounts (filleted). Net assets were £1,980,403, up 34.8% on the previous year. Cash at bank and in hand was £757,711. Total assets were £3,060,739 and total liabilities £1,080,336. The company had an average of 0 employees. Figures are available for 3 financial years (2022/23–2024/25).

Control and charges

1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 9 Nov 2026.